Praxis Precision Medicines (PRAX) statistics

Analysts' price targets and ratings, ownership, short interest, trading figures and dates for Praxis Precision Medicines, as the data feed reports them.

Analysts' mean target, 21 analysts
$674.48
121.1% above the price

The 21 analysts reported by the data feed have a mean price target for Praxis Precision Medicines of $674.48, 121.1% above the $305.06 price (range $189.00–$1,201.00). 15.09% of the float was sold short as of Oct 30, 2026. Institutions hold 127.1% of the shares and insiders 0.3%. Source: Yahoo Finance, read Nov 17, 2026.

Key facts

Analysts' mean target
$674.48+121.1% vs price
Analysts
21
Short interest
15.09%of float, Oct 30, 2026
Short ratio
8.01 days
Institutions
127.1%
Insiders
0.28%
Beta
2.84

Figures read . Source: Yahoo Finance (quoteSummary: key statistics, financial data, recommendation trend, major holders, insider purchases, calendar events). Analysts' targets and ratings, ownership and short interest are the data feed's figures and can lag the filings and exchange reports they come from. Figures, not advice.

Analysts' consensus as reported by the data feed

21 analysts covering Praxis Precision Medicines, as the data feed counts them. Price targets and ratings are other people's estimates — not facts about the company, and not advice. Distances are from the latest price the feed gave with these figures, $305.06.

Analysts' price targets for Praxis Precision Medicines
Mean price target$674.48121.1% above the price (+121.1%)
Median price target$593.0094.4% above the price (+94.4%)
Highest target$1,201.00293.7% above the price (+293.7%)
Lowest target$189.0038.0% below the price (−38.0%)
Analysts with a target21

Ratings this month · 19 analysts

Strong buy 3(16%)Buy 15(79%)Sell 1(5%)
Analysts' ratings of Praxis Precision Medicines this month, by rating
RatingAnalystsShare
Strong buy316%
Buy1579%
Hold00%
Sell15%
Strong sell00%

The feed averages these to 1.37 on its scale of 1 (strong buy) to 5 (strong sell), which it labels “strong buy”.

Who owns Praxis Precision Medicines

Ownership of Praxis Precision Medicines
Held by institutions127.1%471 institutions; percent of shares outstanding
Held by institutions, of the float127.5%
Held by insiders0.28%percent of shares outstanding
Shares outstanding27.95M
Float24.11Mshares available to trade
Insiders' net purchases, six months+34.63K15 purchases (46.23K shares), 1 sales (11.6K shares)

Percentages are of shares outstanding unless the row says float. Insiders' net purchases are shares bought minus shares sold by insiders, as the data feed totals their reported trades.

Short interest as reported by the data feed

Shares sold short and not yet covered, as of Oct 30, 2026. Short interest is counted twice a month, so this is not today's figure.

Short interest in Praxis Precision Medicines
Shares short4.21Mas of Oct 30, 2026
Percent of float15.09%shares short ÷ float
Percent of shares outstanding15.06%shares short ÷ shares outstanding
Short ratio (days to cover)8.01shares short ÷ average daily volume

Praxis Precision Medicines short interest from FINRA, with its history

Trading figures

Trading figures for Praxis Precision Medicines
Beta2.84movement against the market; 1 moves with it
52-week high$392.70
52-week low$160.11
Average volume, 3 months462.44Kshares a day
Average volume, 10 days525.09Kshares a day

Questions and answers

What is the analysts' price target for Praxis Precision Medicines (PRAX)?

As reported by the data feed, the mean price target of the 21 analysts covering Praxis Precision Medicines is $674.48, 121.1% above the latest price of $305.06. The highest target is $1,201.00 and the lowest $189.00. Targets are analysts' estimates, not facts about the company and not advice.

How do analysts rate Praxis Precision Medicines stock?

Of the 19 ratings the data feed reports for the current month, 3 are strong buy, 15 buy, 0 hold, 1 sell and 0 strong sell.

How many Praxis Precision Medicines shares are sold short?

As reported by the data feed, 4.21M shares were sold short, 15.09% of the float as of Oct 30, 2026. At the average daily volume that is 8.01 days to cover. Short interest is reported twice a month; it is not today's figure.

Who owns Praxis Precision Medicines stock?

As reported by the data feed, institutions hold 127.1% of the shares (471 institutions) and insiders 0.3%. There are 27.95M shares outstanding, of which 24.11M are in the float.

How much does Praxis Precision Medicines stock move with the market?

Its beta, as reported by the data feed, is 2.84: a beta above 1 means the share has tended to move more than the market, below 1 less. Over the past 52 weeks it traded between $160.11 and $392.70.

Cite this page

Funkfolio, “Praxis Precision Medicines (PRAX) statistics and analyst targets”, data as of 17 November 2026. https://funkfolio.com/stock/PRAX/statistics

Underlying data: Yahoo Finance.